Add BrightSurf on Google Email

Digital and group-based lifestyle counselling to prevent type 2 diabetes shows real-world effectiveness in Finnish health care

A one-year lifestyle intervention with a digital app and group counselling improved diet quality, reduced abdominal obesity and insulin resistance among 2907 Finnish adults at risk of type 2 diabetes. The study suggests that commitment to lifestyle counselling supports positive changes.

SourceUniversity of Eastern Finland·JournalThe Lancet Regional Health - Europe·DateOct 27, 2022

Chinese researchers reveal SERCA2a as a molecular link between insulin resistance and the early pathogenesis of diabetic cardiomyopathy

A recent study published in Life Metabolism found that impaired phosphorylation of SERCA2a plays a bidirectional role in myocardial insulin resistance, dysregulation of calcium homeostasis, and the early stages of DCM. This mechanism involves the regulation of protein stability and insulin receptor maturation.

SourceHigher Education Press·JournalLife Metabolism·TypeExperimental study·DateSep 28, 2022

JAMA study, led by Heritage College faculty, finds association between high insulin dosage and cancer

A recent JAMA study found a positive association between high insulin dosage and cancer incidence among patients with type 1 diabetes. The study suggests that clinicians may need to balance cancer risk when treating patients on high insulin doses, with improving insulin sensitivity potentially being a preferred approach.

SourceOhio University·JournalJAMA·TypeData/statistical analysis·DateJul 29, 2022

Adolescent arterial stiffness – a novel risk factor for hypertension and insulin resistance in young adulthood and for type 2 diabetes mellitus in mid-adulthood

Arterial stiffness in adolescence is a novel risk factor for hypertension, insulin resistance, and type 2 diabetes in young adulthood and mid-adulthood. Risk factors include maternal smoking habits, early life smoking patterns, high salt intake, genetic inheritance, obesity, and elevated blood pressure from childhood.

SourceUniversity of Eastern Finland·JournalJournal of Hypertension·DateJul 25, 2022

“Unlocking” sarcopenic obesity: A review in portal hypertension & cirrhosis provides clarity on key aspects of disease impact and treatment

Researchers from Tianjin Medical University General Hospital review sarcopenic obesity's impact on liver disease, including nonalcoholic fatty liver disease and cirrhosis. The study aims to clarify the pathogenesis of sarcopenic obesity and identify potential therapeutic avenues.

SourceCactus Communications·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateJul 6, 2022

Western diets rich in fructose and fat cause diabetes via glycerate-mediated loss of pancreatic islet cells

A high-fat diet can lead to increased fructose metabolism in the small intestine, resulting in the release of glycerate into circulation. This can cause damage to insulin-producing pancreatic beta cells, increasing the risk of glucose tolerance disorders and Type 2 diabetes mellitus.

SourceTerasaki Institute for Biomedical Innovation·JournalCell Metabolism·TypeExperimental study·DateJun 9, 2022

Oregon State research sheds light on why not all obese patients develop type 2 diabetes

Researchers at Oregon State University have developed a new analytical method that reveals why some obese patients develop type 2 diabetes while others don't. The study found that a particular type of gut microbe leads to insulin resistance, and treatments targeting microbiota may be a new therapeutic strategy for the disease.

SourceOregon State University·JournalJournal of Experimental Medicine·TypeExperimental study·DateJun 3, 2022

Can weekly prednisone treat obesity?

A new study from Northwestern University found that once-weekly prednisone treatment improved exercise endurance, increased lean body mass, and reduced weight in obese mice. The treatment also promoted nutrient uptake into muscles and increased adiponectin levels, a hormone that helps protect against diabetes and insulin resistance.

SourceNorthwestern University·JournalJournal of Experimental Medicine·TypeExperimental study·DateApr 1, 2022

Diabetes drug from the group of SGLT2 inhibitors normalizes insulin action in the brain

Researchers found that SGLT2 inhibitor empagliflozin can improve insulin sensitivity in the brain, leading to better glucose control and reduced liver fat content. This breakthrough discovery positions SGLT2 inhibitors as a potential treatment for insulin resistance in the brain.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalDiabetes Care·TypeRandomized controlled/clinical trial·DateDec 20, 2021

People with high-risk prediabetes benefit from intensive lifestyle intervention

Individuals with high-risk prediabetes significantly improved their blood glucose levels through more exercise and healthy eating behavior, while those at low risk showed limited benefits from conventional lifestyle intervention. The study's findings support personalized interventions tailored to each patient's risk profile for effecti...

Healthier tapioca starch is on the way

Researchers at RIKEN have developed a healthier form of tapioca starch by suppressing multiple genes that increase its resistance to digestion. The resulting starch is composed of longer chains with fewer branches, making it harder to digest and potentially improving intestinal function and blood sugar control.

SourceRIKEN·JournalPlant Molecular Biology·DateDec 16, 2021

A potential protector against a mild heart attack’s aftereffects on metabolism

A study in mice suggests that transplanted brown fat can reduce type 2 diabetes risk factors after a heart attack by dampening gene activation linked to negative effects. The transplantation method could help researchers understand the mechanisms behind this protective effect and potentially lead to therapeutic applications.

SourceOhio State University·JournalInternational Journal of Obesity·TypeExperimental study·DateDec 15, 2021

Deleting dysfunctional cells alleviates diabetes

Researchers at UConn Health have discovered that eliminating senescent cells in human fat tissue can alleviate signs of diabetes and improve insulin sensitivity. The study suggests that clearing away these dysfunctional cells could lead to game-changing new treatments for Type 2 diabetes.

SourceUniversity of Connecticut·JournalCell Metabolism·TypeExperimental study·DateNov 22, 2021

Researchers observed association between standing and insulin sensitivity – standing more may help prevent chronic diseases

A Finnish study discovered a positive association between standing and improved insulin sensitivity in adults with increased risk of type 2 diabetes and cardiovascular diseases. The researchers found that increasing daily standing time can help prevent chronic diseases, even if physical activity recommendations are not met.

SourceUniversity of Turku·JournalJournal of Science and Medicine in Sport·TypeImaging analysis·DateSep 10, 2021

How migraines protect against diabetes

Researchers found that certain peptides associated with migraine pain can regulate insulin production in mice, potentially preventing type 2 diabetes. The study suggests that these peptides could be developed into therapeutic strategies to control blood sugar levels, while minimizing the risk of migraines.